Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Increases By 85.5%

Virax Biolabs Group Limited (NASDAQ:VRAX) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 164,900 shares, a growth of 85.5% from the December 15th total of 88,900 shares. Based on an average daily trading volume, of 1,790,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 4.1% of the company’s shares are short sold.

Virax Biolabs Group Trading Down 1.7 %

VRAX stock opened at $2.38 on Tuesday. Virax Biolabs Group has a 1-year low of $0.60 and a 1-year high of $9.00. The business’s 50-day moving average price is $2.01 and its two-hundred day moving average price is $2.12.

About Virax Biolabs Group

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name.